REVIEW
|
doi:10.20944/preprints202311.0716.v1
Subject:
Medicine And Pharmacology,
Obstetrics And Gynaecology
Keywords:
borderline ovarian tumors; molecular features; mutations; genetic mutations; BRAF; KRAS; NRAS; ARID1A; CADM1; PIK3CA; CHEK2; CLAUDIN-1; ERBB2; loss of heterozygosity; PTEN; microsatellite instability
Online: 13 November 2023 (08:32:29 CET)